Brief: Genedrive Says Cyp2c19-Id Kit Adopted For Routine Clinical Use
14/03/2025 07:22
March 14 (Reuters) - Genedrive PLC GDRG.L: GENEDRIVE PLC - CYP2C19-ID KIT ADOPTED FOR ROUTINE CLINICAL USE Source text: ID:nRSN6193Aa Further company coverage: GDRG.L ((Reuters.Briefs@thomsonreuters.com;))